Staels B - Search Results

1

PPARs: a potential target for a disease-modifying strategy in stroke.

Ouk T, Potey C, Gautier S, Bastide M, Deplanque D, Staels B, Duriez P, Leys D, Bordet R. Ouk T, et al. Among authors: staels b. Curr Drug Targets. 2013 Jun;14(7):752-67. doi: 10.2174/1389450111314070005. Curr Drug Targets. 2013. PMID: 23514380 Review.

2

Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis.

Fruchart JC, Duriez P, Staels B. Fruchart JC, et al. Among authors: staels b. Curr Opin Lipidol. 1999 Jun;10(3):245-57. doi: 10.1097/00041433-199906000-00007. Curr Opin Lipidol. 1999. PMID: 10431661 Review.

3

Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway.

Delerive P, Martin-Nizard F, Chinetti G, Trottein F, Fruchart JC, Najib J, Duriez P, Staels B. Delerive P, et al. Among authors: staels b. Circ Res. 1999 Sep 3;85(5):394-402. doi: 10.1161/01.res.85.5.394. Circ Res. 1999. PMID: 10473669

4

Oxidized phospholipids activate PPARalpha in a phospholipase A2-dependent manner.

Delerive P, Furman C, Teissier E, Fruchart J, Duriez P, Staels B. Delerive P, et al. Among authors: staels b. FEBS Lett. 2000 Apr 7;471(1):34-8. doi: 10.1016/s0014-5793(00)01364-8. FEBS Lett. 2000. PMID: 10760508 Free article.

5

[Molecular mechanism of action of the fibrates].

Fruchart JC, Duriez P, Staels B. Fruchart JC, et al. Among authors: staels b. J Soc Biol. 1999;193(1):67-75. J Soc Biol. 1999. PMID: 10851558 Review. French.

6

The role of fibric acids in atherosclerosis.

Fruchart JC, Staels B, Duriez P. Fruchart JC, et al. Among authors: staels b. Curr Atheroscler Rep. 2001 Jan;3(1):83-92. doi: 10.1007/s11883-001-0015-x. Curr Atheroscler Rep. 2001. PMID: 11123853 Review.

7

PPARalpha agonists inhibit tissue factor expression in human monocytes and macrophages.

Neve BP, Corseaux D, Chinetti G, Zawadzki C, Fruchart JC, Duriez P, Staels B, Jude B. Neve BP, et al. Among authors: staels b. Circulation. 2001 Jan 16;103(2):207-12. doi: 10.1161/01.cir.103.2.207. Circulation. 2001. PMID: 11208678

8

[New concepts on the mechanism of action of fibrates and therapeutic prospectives in atherosclerosis].

Fruchart JC, Staels B, Duriez P. Fruchart JC, et al. Among authors: staels b. Bull Acad Natl Med. 2001;185(1):63-74; discussion 74-5. Bull Acad Natl Med. 2001. PMID: 11474570 Review. French.

9

PPARS, metabolic disease and atherosclerosis.

Fruchart JC, Staels B, Duriez P. Fruchart JC, et al. Among authors: staels b. Pharmacol Res. 2001 Nov;44(5):345-52. doi: 10.1006/phrs.2001.0871. Pharmacol Res. 2001. PMID: 11712864 Review.

10

HMG-CoA reductase inhibition and PPAR- alpha activation both inhibit cyclosporin A induced endothelin-1 secretion in cultured endothelial cells.

Kandoussi A, Martin F, Hazzan M, Noël C, Fruchart JC, Staels B, Duriez P. Kandoussi A, et al. Among authors: staels b. Clin Sci (Lond). 2002 Aug;103 Suppl 48:81S-83S. doi: 10.1042/CS103S081S. Clin Sci (Lond). 2002. PMID: 12193060

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

791 results

Search Page